Option chain shows key data for Venus Concept's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Venus Concept.

Venus Concept (NASDAQ:VERO) Stock, Option Chain

Venus Concept

Venus Concept Inc is a medical technology company. It develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services. The company's products include NeoGraft, Venus Viva, Venus Legacy, Venus Versa, Venus Velocity, Venus Bliss, ARTAS systems, and others. The company provides medical devices and treatments for hair, body, and skin-related problems. It generates a majority of its revenue from the United States.

Nasdaq index

Equities

News

Eurozone

Commodities

Intraday Update

Markets

Trading Ideas

ENVB

FLYW

GERN

MULN

PRCH

VERO

Nasdaq Surges 150 Points; Lowe&#39;s Posts Upbeat Earnings

movers image

Pre-Market Outlook

Movers

APLD

BTBT

BTDR

CIFR

CRVS

MSTR

STLA

Stellantis, MicroStrategy, Bit Digital And Other Big Stocks Moving Lower In Monday&#39;s Pre-Market Session

Nio Photo by Sundry Photography on Shutterstock

DADA

ENSC

FTFT

GSIW

KXIN

RELI

UXIN

VERB

VSME

ZCMD

Why Nio Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket

Venus Concept Inc

VERONI BRANDS CORP by Veroni Brands Corporation

Verona Pharma plc - American Depositary Shares

Verona Pharma PLC

Press Releases

Venus Concept Announces Regulatory Approval for Venus Bliss MAX in Canada

Earnings

Venus Concept Announces Second Quarter of Fiscal Year 2024 Financial Results

General

Venus Concept Announces Australian Regulatory Approval for Venus Bliss MAX

Venus Concept Announces $15 million Debt-to-Equity Exchange Transaction

Venus Concept to Release Third Quarter of Fiscal Year 2024 Financial Results on November 13, 2024

Venus Concept Announces Expansion of International Distribution Network and Certification of Products in India

Venus Concept Announces Third Quarter of Fiscal Year 2024 Financial Results

Venus Concept Announces Senior Management Changes

Venus Concept Announces 1-for-11 Reverse Stock Split

Venus Concept to Release Fourth Quarter and Fiscal Year 2024 Financial Results on March 31, 2025

Aspira Women's Health Inc. - Common Stock

Aspira Womens Health

Bluejay Diagnostics

GlucoTrack

HeartSciences

Helius Medical Technologies, Inc. - Class A Common Stock

Helius Medical Tech

Know Labs

LogicMark

NanoVibronix

ENDRA Life Sciences

ReShape Lifesciences, Inc. - Common Stock

Reshape Lifesciences

SINTX Techs

Tivic Health Systems, Inc. - Common stock

Tivic Health Systems

Tenon Medical

Catheter Precision

Ladenburg Thalmann

Comments

Venus Concept

Venus Concept (VERO) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga